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Abstract: Six new organotin(IV) compounds of Schiff bases derived from S-R-dithiocarbazate  
[R = benzyl (B), 2- or 4-methylbenzyl (2M and 4M, respectively)] condensed with 2-hydroxy-3-
methoxybenzaldehyde (oVa) were synthesised and characterised by elemental analysis, various 
spectroscopic techniques including infrared, UV-vis, multinuclear (1H, 13C, 119Sn) NMR and mass 
spectrometry, and single crystal X-ray diffraction. The organotin(IV) compounds were synthesised 
from the reaction of Ph2SnCl2 or Me2SnCl2 with the Schiff bases (S2MoVaH/S4MoVaH/SBoVaH) to 
form a total of six new organotin(IV) compounds that had a general formula of [R2Sn(L)] (where L 
= Schiff base; R = Ph or Me). The molecular geometries of Me2Sn(S2MoVa), Me2Sn(S4MoVa) and 
Me2Sn(SBoVa) were established by X-ray crystallography and verified using density functional 
theory calculations. Interestingly, each experimental structure contained two independent but 
chemically similar molecules in the crystallographic asymmetric unit. The coordination geometry 
for each molecule was defined by thiolate-sulphur, phenoxide-oxygen and imine-nitrogen atoms 
derived from a dinegative, tridentate dithiocarbazate ligand with the remaining positions occupied 
by the methyl-carbon atoms of the organo groups. In each case, the resulting five-coordinate C2NOS 
geometry was almost exactly intermediate between ideal trigonal-bipyramidal and square-
pyramidal geometries. The cytotoxic activities of the Schiff bases and organotin(IV) compounds 
were investigated against EJ-28 and RT-112 (bladder), HT29 (colon), U87 and SJ-G2 (glioblastoma), 
MCF-7 (breast) A2780 (ovarian), H460 (lung), A431 (skin), DU145 (prostate), BE2-C (neuroblastoma) 
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and MIA (pancreatic) cancer cell lines and one normal breast cell line (MCF-10A). Diphenyltin(IV) 
compounds exhibited greater potency than either the Schiff bases or the respective dimethyltin(IV) 
compounds. Mechanistic studies on the action of these compounds against bladder cancer cells 
revealed that they induced the production of reactive oxygen species (ROS). The bladder cancer 
cells were apoptotic after 24 h post-treatment with the diphenyltin(IV) compounds. The interactions 
of the organotin(IV) compounds with calf thymus DNA (CT-DNA) were experimentally explored 
using UV-vis absorption spectroscopy. This study revealed that the organotin(IV) compounds have 
strong DNA binding affinity, verified via molecular docking simulations, which suggests that these 
organotin(IV) compounds interact with DNA via groove-binding interactions. 
Keywords: tridentate ONS Schiff bases; organotin(IV); dithiocarbazate; five-coordinate compounds; 
single-crystal X-ray diffraction analysis; cytotoxic activity; mechanistic studies; molecular docking 
 
1. Introduction 
The International Agency for Research on Cancer reported a global incidence of 18.1 million new 
cancer cases and 9.6 million deaths in 2018, with the number of new cases expected to increase rapidly 
over the next two decades [1,2]. Chemotherapy remains the most widely-used cancer treatment, as 
compared to surgery, radiation therapy, immunotherapy, hormone therapy and targeted therapy. 
Cisplatin is a long-standing effective chemotherapy agent for a number of cancers including 
testicular, ovarian, cervical, head and neck, bladder, lung and colorectal cancer [3,4]. Platinum-based 
compounds such as carboplatin, oxaliplatin, nedaplatin and laboplatin are also effective 
chemotherapeutic agents against tumours [5]. A probable mechanism of action for cisplatin is via the 
interaction with DNA though the formation of covalent adducts [4]. However, platinum drugs have 
been known to cause various side-effects including anaemia, diarrhoea, alopecia, petechiae, fatigue, 
nephrotoxicity, emetogenesis, ototoxicity, neurotoxicity and increasing chemotherapeutic resistance 
[6]. This has sparked wide-spread research in the synthesis and evaluation of novel non-platinum-
based complexes as alternative chemotherapeutic agents. 
In recent years, metal compounds with a stable d10 electronic configuration have received 
considerable attention due to the wide variety of structures formed that depend on the coordinating 
ligands and synthetic procedures [7–16]. Organotin(IV) compounds have found use in industry, 
medicine and agriculture as stabilisers in polyvinylchloride (PVC) plastics, catalysts [17], anti-fouling 
paints, fungicides [10], wood preservatives and disinfectants [18]. Organotin(IV) compounds have 
also been reported as effective biocidal agents against environmental toxicants [19,20]. Their 
medicinal applications (such as anti-tumour, anti-microbial, anti-nematicidal, anti-insecticidal and 
anti-inflammatory agents) have been explored [7,21–23]. The National Cancer Institute (NCI) has 
tested over 2000 tin-based pharmacological candidates, the largest number ever tested among the 
metal-containing drug candidates [24]. 
Many mechanistic studies on organotin(IV) compounds have indicated that these compounds 
interact with DNA [25,26], one of the main targets in designing cytotoxic drugs and the biological 
activity of organotin(IV) compounds is believed to arise from their tendency in binding to or cleaving 
DNA [27,28]. Wang et al. reported that organotin(IV) compounds containing Schiff bases could 
interact with CT-DNA through intercalation interactions of cytotoxic drugs and serum albumin 
(which is involved in the transportation of compounds through the blood stream), where the nature 
and magnitude of these interactions that could significantly influence the pharmacokinetics have also 
been investigated [29,30]. Organotin(IV) derivatives bind to both nitrogenous DNA bases and 
phosphate-oxygen of the DNA sugar backbone [31,32]. Organotin(IV) compounds have been 
reported to bind to glycoprotein or cellular proteins, hence interacting directly with DNA, causing 
cell death. Tin(IV) compounds have also been found to induce DNA damage by specifically binding 
to the phosphate backbone of DNA thus leading changes in DNA conformations [33].  
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The activity of organotin(IV) compounds can be readily modified by the choice of ligand 
coordinated to the central Sn(IV) ion. Organotin(IV) centres coordinated to hetero-donor atoms, 
especially oxygen, nitrogen and sulphur, have been investigated with a particular focus on their 
structure-activity correlations [34–36]. Coordination of metals to multidentate Schiff bases have, in 
most cases, enhanced the biological activity of these compounds [37–39]. Tin(IV) compounds of Schiff 
bases containing pyridine have been reported to be particularly biologically relevant [38,40,41]. 
In order to expand therapeutic potential of organotin(IV) compounds of dithiocarbazate 
derivatives, and in light of the biological relevance of previously reported organotin(IV) compounds, 
we report herein the synthesis of three Schiff bases derived from 2-hydroxy-3-methoxybenzaldehyde 
dithiocarbazate and six of their organotin(IV) compounds. The X-ray crystal structures of 
dimethyltin(IV) compounds were determined, and their geometries were compared with theoretical 
DFT calculations at the Becke, 3-parameter, Lee–Yang–Parr (B3LYP) level of theory. The Schiff bases 
and organotin(IV) compounds were tested for their cytotoxicity via various assays, which was 
supported by DNA binding studies. 
2. Results and Discussion 
2.1. Synthesis 
Schiff bases, S2MoVaH, S4MoVaH and SBoVaH, were prepared by reacting S-N-R-
benzyldithiocarbazates (N = 2,3, R = methyl) and oVa in equimolar ratios (Scheme 1). The Schiff bases 
were obtained in good yields. The organotin(IV) compounds were synthesised using the 
corresponding diorganotin(IV) dichloride salts under reflux as shown in Scheme 2. The Schiff bases 
and their organotin(IV) compounds are yellow, stable at room temperature and soluble in organic 
solvents (especially chloroform, dimethyl sulfoxide (DMSO) and dimethylformamide (DMF). The 
room temperature molar conductance values of the organotin(IV) compounds in DMSO at a 
concentration of 10−3 M were in the range of 2.30–8.21 Ω−1·cm2·mol−1, i.e., values well below 25 
Ω−1·cm2·mol−1, indicating that these organotin(IV) compounds are non-electrolytes proving the 
absence of counter-ions, thus indicating that the dithiocarbazate Schiff bases were covalently bonded 
to the central organotin ion [42]. 
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Scheme 1. Synthetic pathway for the formation of SBoVaH, S2MoVaH, and S4MoVaH. 
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Scheme 2.  Synthesis of organotin(IV) compounds. 
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2.2. IR Spectral Analysis 
The IR spectra indicated the successful formation of the dithiocarbazate Schiff bases and their 
organotin(IV) compounds. Infrared spectra of Schiff bases and their organotin(IV) compounds were 
measured in the range 4000 to 280 cm−1 and verified using frequencies predicted using density 
functional theory (DFT). All DFT vibrational frequencies were scaled using a scaling factor of 0.9682 
[43] (see Section 3.5.1 for full details of DFT calculations). The Schiff bases have a thioamide(–NH–
CS–) functional group and thus, can exist either in the thione (Figure 1a) or thiol (Figure 1b) forms or 
as a mixture of both thione and thiol tautomeric forms. In the solid-state, the Schiff bases are primarily 
in the thione form as shown by the presence of the v(NH) band at 3089 cm−1 and absence of the v(SH) 
band at c.a. 2600 cm−1 [44]. Characteristic vibrational frequencies consistent with the successful 
formation of organotin(IV) compounds have been identified. The v(NH) stretching vibration at ca 
3084–3092 cm−1 was absent in the organotin(IV) compounds indicating that the Schiff bases were 
deprotonated upon complexation. Sharp v(C=N) bands corresponding to the Schiff base azomethine 
group at 1600 (S2MoVaH), 1598 (S4MoVaH) and 1598 (SBoVaH) cm−1 were observed to shift to lower 
wavenumbers upon complexation which indicated coordination via the azomethine nitrogen [45]. 
The v(CSS) splitting bands found in the range 956–964 cm−1 provide strong evidence of coordination 
of the thiolate sulphur atom to the tin ion. The shifting of the hydrazinic v(N–N) band to lower 
wavenumbers in the organotin(IV) compounds showed evidence of coordination via the azomethine 
nitrogen due to reduction in the repulsion between lone pairs of electrons on the nitrogen atom [46–
48]. The calculated frequencies correlated well with the experimental frequencies observed in the FT-
IR spectra, considering that DFT frequency calculations were performed in the gas-phase. The N–H 
band in the experimental FTIR spectra of Schiff bases red-shifted owing to intermolecular hydrogen 
bonding [49]. The absence of hydroxyl stretching in the experimental spectra of the Schiff bases could 
be due to intermolecular and intramolecular hydrogen bonding as was observed in similar reported 
organotin(IV) compounds [50]. Moreover, only slight differences were observed in the experimental 
and calculated data for v(C=N), v(N–N) and v(C=S). Complete IR data are provided in Table S1.  
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Figure 1. The thione (a) and thiol (b) tautomeric forms of the Schiff bases (R = o–CH3, S2MoVaH; p-
CH3, S4MoVaH; R = H, SBoVaH). 
2.3. NMR Spectroscopic Analysis 
NMR spectra of the dithiocarbazate Schiff bases were recorded in DMSO-d6, while the NMR 
spectra of their organotin(IV) compounds were recorded in CDCl3. The data obtained were in good 
agreement with the expected structures in both solvents. The absence of the exchangeable SH signal 
in the 1H NMR spectra of the Schiff bases indicated the predominance of the thione tautomer in 
DMSO-d6 [51]. The spectra of the Schiff bases also exhibited a downfield signal at ~13.32–13.34 ppm 
due to the NH group. For all organotin(IV) compounds, the 1H NMR signal for the azomethine NH 
proton was absent due to the coordination to the metal ion by the Schiff base, in corroboration with 
the absence of the v(NH) FTIR band noted in Section 2.2. A singlet appeared in the downfield region 
of the 1H NMR spectra of the Schiff bases which corresponded to an sp2-C–OH proton. Proton 
chemical shifts for both NH and OH disappeared in the spectra of the organotin(IV) compounds 
suggesting double deprotonation of the Schiff bases and supporting coordination of both the 
phenolic-oxygen and -nitrogen atoms of the Schiff base to the tin ion. 
The 13C NMR spectra of the dithiocarbazate Schiff bases showed a downfield chemical shift at 
~196 ppm, indicating the existence of the C=S group and thus the predominance of the thione 
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tautomer in solution. This signal was shifted upfield in the organotin(IV) compounds (170–180 ppm), 
indicating a decrease in electron density at the C=S carbon atom when the sulphur atom was 
complexed to the tin ion, consistent with the structures proposed for the organotin(IV) compounds 
[52].  
The 119Sn NMR spectra of the organotin(IV) compounds were recorded at room temperature in 
CDCl3 using SnMe4 as the external standard. Theoretically, as the coordination number about tin 
increases, chemical shifts in 119Sn NMR move towards lower frequencies [53]. 119Sn NMR spectra are 
also very sensitive to the type of donor atom coordinated to the tin and its environment, e.g., alkyl or 
aryl groups in the case of a C donor and to the bond angles around the tin centre [54]. However, 
shielding or deshielding of the tin nucleus does not have a significant effect on the chemical shifts 
[55]. Dimethyltin(IV) compounds showed less negative 119Sn chemical shifts compared to 
diphenyltin(IV) compounds. The chemical shift values obtained were within the range reported for 
other diphenyl- or dimethyl(IV) compounds with heterocyclic ligands having penta-coordinated 
trigonal bipyramidal geometry [53,56]. Complete 119Sn NMR data are provided in Section 3.3. The 
NMR details for the Schiff bases and organotin(IV) compounds are tabulated in Tables S2 and S3. 
2.4. Mass Spectral Analysis 
Mass spectral data for the Schiff bases were recorded in DMSO and were found to be consistent 
with the proposed formulation of the Schiff bases. Mass spectra displayed prominent peaks at m/z 
346.15 and 346.10 for S2MoVaH and S4MoVaH, respectively, corresponding to [C17H18N2O2S2]+, and 
m/z 332.10 for SBoVaH corresponding to [C16H16N2O2S2]+. 
2.5. X-ray Crystallography 
The crystal structures of Me2Sn(S2MoVa), Me2Sn(S4MoVa) and Me2Sn(SBoVa), each featured 
two independent molecules in the crystallographic asymmetric unit, i.e., molecules a and b. Figure 
2a–c shows the molecular structures for the first independent molecule in each crystal and images for 
the second independent molecules are shown in Figures 3a, 4a and 5a; selected geometric parameters 
are collated in Table 1. The major conformational difference between the molecules in each of 
Me2Sn(S2MoVa), Me2Sn(S4MoVa) and Me2Sn(SBoVa) is highlighted in the overlay diagram shown in 
Figure 2d. Whereas in the tolyl species, the tolyl substituent is orientated to be directed away from 
the coordinated S1 atom, i.e., can be considered anti to S1, in each molecule of Me2Sn(S4MoVa), the 
phenyl ring is syn to the S1 atom. 
The tin atom in Me2Sn(S2MoVa) is coordinated by the thiolate-S1, phenoxide-O1 and imine-N 
atoms derived from the dinegative, [(3-methoxy-2-oxyphenyl)methyl] dithiocarbazate ligand. The 
five-coordinate geometry is completed by a carbon atom from each of the two methyl groups. The 
assignment of thiolate-S1 is readily made by comparing the length of the C1‒S1 bond in 
Me2Sn(S2MoVa), i.e., 1.726(9) and 1.717(8) Å, for the two independent molecules comprising the 
asymmetric unit, with that in the uncoordinated Schiff base (which lacks the 2-methyl group in the 
ester group) of 1.670(2) Å [50], i.e., the bond lengths in Me2Sn(S2MoVa) are significantly longer. The 
C1‒S2 bond lengths are experimentally equivalent at 1.744(8) and 1.747(8) Å [50]. However, the two 
C1=N1 imine bond lengths in Me2Sn(S2MoVa) are 1.304(11) and 1.273(10) Å, which are significantly 
longer than the equivalent C1‒N1(H) bond of 1.338(2) Å in the free Schiff base [50]. The mode of 
coordination of the dithiocarbazate ligand leads to the formation of five- and six-membered chelate 
rings, with the chelate angle in the former being approximately 5° more acute than that in the latter, 
Table 1. The Sn, S1, N1, N2, C1 chelate ring in molecule a is non-planar and is twisted about the Sn‒
S1 bond. On the other hand, the Sn, O1, N1, C10–C12 chelate ring is best described as having an 
envelope conformation whereby the Sn atom lies 0.528(11) Å above the plane. However, the structure 
of the second independent molecule in the asymmetric unit, molecule b, is slightly different whereby 
the five-membered ring is an envelope with the Sn atom lying 0.372(12) Å above the plane defined 
by the remaining four atoms in this ring [r.m.s. deviation = 0.008 Å]. The six-membered ring is also 
an envelope with the Sn atom lying 0.528(11) Å out of the plane defined by the five remaining atoms 
which present a r.m.s. deviation = 0.022 Å. The dihedral angle between the best planes through the 
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chelate rings in the molecule a is 11.12(17)° while for molecule b, the equivalent angle is 12.4(3)°. The 
benzyl ring is almost orthogonal to the five-membered chelate ring for both independent molecules 
in the unit cell, forming dihedral angles of 88.3(3) and 86.8(3)°, respectively. Similarly, the dihedral 
angles between the outer rings are 72.3(3) and 75.5(3)°, respectively, also indicating an approximate 
orthogonal relationship. The similarity between the conformations found for the two independent 
molecules in the asymmetric unit is highlighted in the overlay diagram shown in Figure 3. The five-
coordinate geometry defined by the C2NOS donor set for molecule a, with five-coordinate geometry 
descriptor τ = 0.48, is intermediate between ideal square-pyramidal (τ = 0.0) and trigonal-bipyramidal 
geometries (τ = 1.0) [57]; the value of τ is 0.50 for molecule b. For each independent molecule, the 
widest angle corresponds to the S1‒Sn‒O1 angle with the second widest angle being subtended by 
the tin-bound methyl groups. The angles about the quaternary-C1 atom span nearly 20° with the 
widest angles involving the doubly bonded N1 atom. Of these, the angle involving the S1 atom, being 
the widest, is consistent with some double bond character in the C1‒S1 bond. Consistent with this, 
(see Table 1), the C1‒S1 bond lengths are systematically shorter than the C1‒S2 bonds. 
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Figure 2. Molecular structures of the first independent molecules of (a) Me2Sn(S2MoVa), (b) 
Me2Sn(S4MoVa) and (c) Me2Sn(SBoVa) showing atom labelling schemes. (d) Overlay diagram of the 
two independent molecules of each of Me2Sn(S2MoVa), a (red image) and b (green), Me2Sn(S4MoVa), 
a (blue) and b (pink), and Me2Sn(SBoVa) a (yellow) and b (aqua) with the SnMe2 planes superimposed. 
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Figure 3. Crystallographic diagrams for Me2Sn(S2MoVa): (a) Molecular structure of the second 
independent molecule, molecule b, (b) overlay diagram of molecules a (red image) and inverted-b 
(green) drawn so the SnC2 atoms of the Me2Sn moiety are overlapped and (c) a view of the 
supramolecular layer in the ab-plane (left image) and a view of the unit cell contents in projection 
down the a-axis with one layer highlighted in space-filling mode (right image). The C‒H…O and C‒
H…π interactions are shown as orange and purple dashed lines, respectively. 
The isomeric compound, Me2Sn(S4MoVa), having an ester 4-tolyl residue rather than 2-tolyl, 
presents very similar characteristics to those exhibited in the structure of Me2Sn(S2MoVa) (Figure 2b, 
Figure 4 and Table 1). The conformations of the two chelate rings in the independent molecules are 
the approximately same, being based on an envelope conformation with the tin atom being the flap 
in all cases. The envelope is more pronounced, cf. Me2Sn(S2MOVa), in the five-membered rings with 
the tin atom lying 0.486(4) Å [0.490(4) Å for molecule b] above the plane of the four remaining atoms 
which have a r.m.s. deviation = 0.009 Å [0.012 Å] but, is somewhat flattened in the six-membered 
rings with the tin atom lying 0.187(4) Å [0.132(4) Å] out of the plane defined by the five remaining 
atoms with a r.m.s. deviation = 0.013 Å [0.017 Å]. The dihedral angle between the best planes through 
the chelate rings is 10.24(8)° [8.53(11)°]. Near orthogonal relationships between the five-membered 
chelate rings and the pendant tolyl rings persist, and the dihedral angles between the outer phenyl 
rings is 65.75(10)° [78.30(10)°]. The value of τ is 0.54 [0.41]. A difference is noted in the coordination 
geometries in that the second widest angles at the tin atom, after S1‒Sn‒O1, are subtended by the N2 
and C19 atoms, i.e., 125.83(12)° [131.09(12)°], rather than the C18‒Sn‒C19 angle, Table 1. 
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Figure 4. Crystallographic diagrams for Me2Sn(S4MoVa): (a) Molecular structure of the second 
independent molecule, molecule b, (b) overlay diagram of molecules a (blue image) and inverted-b 
(pink) drawn so the SnC2 atoms of the Me2Sn moiety are overlapped and (c) a view of the 
supramolecular dimer sustained by C‒H…π (chelate) interactions (left image; non-participating 
hydrogen atoms have been omitted) and a view of the unit cell contents in projection down the a-axis. 
The C‒H…O and C‒H…π interactions are shown as orange and purple dashed lines, respectively. 
The unsubstituted analogue of the aforementioned isomeric structures, i.e., Me2Sn(SBOVa), is 
similar to those just described (Figures 2c and 5, Table 1). A likely trend in the Sn‒S1 bond lengths 
may be discerned, Table 1, in that these are longest in Me2Sn(SBOVa) compared to the tolyl 
derivatives, Me2Sn(S2MOVa) and Me2Sn(S4MOVa), pointing to an electronic influence, i.e., activation 
of the aromatic ring owing to the presence of electron-donating methyl groups; while there is 
evidence for shorter Sn‒S1 bond lengths in Me2Sn(S4MOVa) cf. Me2Sn(S2MOVa), the standard 
uncertainty values in the latter preclude a definitive statement on this although the trend for shorter 
Sn‒S1 bonds in Me2Sn(S4MOVa) is consistent with expectation. The conformational flexibility in the 
chelate ligands formed by these tridentate ligands is reflected in the flattened envelope conformations 
for the five-membered rings with the Sn atom lying 0.326(6) Å above the plane defined by the four 
remaining atoms [r.m.s. deviation = 0.021 Å; comparable parameters for molecule b are 0.287(6) and 
0.024 Å, respectively]. By contrast, pronounced envelope conformations are found for the six-
membered rings [0.675(5) and 0.043 Å for molecule a; 0.706(5) and 0.048 Å for molecule b]. The 
dihedral angle between the best planes through the chelate rings is 13.66(16)° [13.92(17)°]. The values 
of τ for the independent molecules compute to 0.47 and 0.44, respectively. As for Me2Sn(S4MOVa), 
after the S1‒Sn‒O1 angles, the widest angle subtended at the tin atom in Me2Sn(SBOVa) for the 
second independent molecule involves the coordinated imine-N2 and a tin-bound methyl-C17 atoms, 
i.e., 127.66(17)°. Of the three new structures reported herein, the greatest agreement between the two 
independent molecules comprising the asymmetric unit is found for Me2Sn(S4MOVa), see Figure 5 
and Table 1. 
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Table 1. Selected geometric parameters (Å, °) for Me2Sn(S2MoVa), Me2Sn(S4MoVa) and Me2Sn(SBoVa). 
Parameter Me2Sn(S2MoVa) Me2Sn(S4MoVa) Me2Sn(SBoVa) 
Bond lengths molecule a molecule b 
B3LYP 
molecule a molecule b 
B3LYP 
molecule a molecule b 
B3LYP 
LanL2DZ/6-311G(d,p) LanL2DZ/6-311G(d,p) LanL2DZ/6-311G(d,p) 
Sn‒S1 2.545(2) 2.542(2) 2.576 2.5391(8) 2.5309(7) 2.566 2.5789(11) 2.5607(10) 2.590 
Sn‒O1 2.092(6) 2.102(6) 2.085 2.090(2) 2.214(2) 2.078 2.103(3) 2.093(3) 2.078 
Sn‒N2 2.188(6) 2.192(6) 2.285 2.223(2) 2.088(2) 2.232 2.194(3) 2.205(3) 2.226 
C1‒S1 1.726(9) 1.717(8) 1.751 1.736(3) 1.734(3) 1.753 1.725(4) 1.726(4) 1.748 
C1‒S2 1.744(8) 1.747(8) 1.772 1.752(3) 1.757(3) 1.771 1.771(4) 1.763(4) 1.783 
N1‒N2 1.394(9) 1.406(9) 1.389 1.402(3) 1.409(3) 1.388 1.397(5) 1.395(4) 1.383 
C1‒N1 1.304(11) 1.273(10) 1.293 1.289(4) 1.287(4) 1.293 1.298(5) 1.291(5) 1.296 
C(x)‒N2 1.308(9) 1.306(9) 1.313 1.309(4) 1.307(4) 1.312 1.311(5) 1.304(5) 1.307 
Bond angles          
S1‒Sn‒O1 157.89(17) 158.25(17) 159.5 158.51(7) 155.88(7) 159.7 155.82(9) 154.24(10) 159.8 
S1‒Sn‒N2 77.35(18) 76.94(18) 77.6 77.33(7) 77.78(6) 77.8 76.70(9) 77.13(8) 77.3 
O1‒Sn‒N2 82.2(2) 82.3(2) 82.0 82.13(9) 82.15(8) 82.2 82.76(11) 82.09(12) 82.4 
C18‒Sn‒C(y) 128.9(5) 128.2(5) 123.9 122.58(14) 123.05(14) 123.9 127.70(18) 124.8(2) 123.7 
S1‒C1‒S2 112.1(5) 111.9(5) 113.4 111.46(17) 111.81(17) 113.4 120.2(2) 120.1(2) 120.8 
S1‒C1‒N1 129.1(6) 128.9(6) 128.2 129.1(2) 129.6(2) 128.2 128.7(3) 128.3(3) 127.7 
S2‒C1‒N1 118.9(7) 119.3(6) 118.4 119.5(2) 118.6(2) 118.4 111.1(3) 111.6(3) 111.5 
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Figure 5. Crystallographic diagrams for Sn(SBoVa)Me2: (a) Molecular structure of the second 
independent molecule, molecule b, (b) overlay diagram of molecules a (yellow image) and b (aqua) 
drawn so the five-membered rings are overlapped and (c) supramolecular dimer sustained by edge-
to-edge chelate ring…benzene interactions (upper image) between Sn1-containing molecules, 
supramolecular layer sustained by edge-to-edge π (chelate ring)…π (ethoxybenzene) and phenyl-C‒
H…π (methoxybenzene) interactions occurring between Sn2-containing molecules and a view of the 
unit cell contents in projection down the b-axis. The edge-to-edge π (chelate ring)…π (ethoxybenzene) 
and C‒H…π interactions are shown as blue and purple dashed lines, respectively. 
In the absence of conventional hydrogen bonding interactions, the crystals of Me2Sn(S2MoVa), 
Me2Sn(S4MoVa) and Me2Sn(SBoVa) feature a range of weak non-covalent interactions. Packing 
diagrams are given in Figures 3c, 4c and 5c and geometric details characterising the specified 
intermolecular interactions are given in Tables S4-S6. In the molecular packing of Me2Sn(S2MoVa), 
imine-C‒H…O(phenoxide), methylene-C‒H…π(methoxybenzene), involving both methylene groups, 
and tin-bound-methyl-C‒H…π (tolyl) interactions combine to stabilise supramolecular layers in the 
ab-plane; layers stack without directional interactions between them. The crystal of Me2Sn(S4MoVa) 
features additional recognisable points of contact between molecules largely due to the participation 
of the methoxy substituents. Thus, tolyl-C‒H…O (methoxy) and methoxy-methyl-C‒H…O (methoxy, 
phenoxide) interactions are apparent as are tolyl-C5‒H…π(chelate) and tin-bound-methyl-C‒
H…π(tolyl) points of contact. These consolidate the three-dimensional architecture, see Figure 4c. The 
presence of C‒H…π (chelate) interactions is of interest and have only relatively recently been 
appreciated as being important in contributing to the stability of coordination compounds [58–60]. 
These interactions usually stabilise (centrosymmetric) dimeric aggregates [59] and that is the case in 
Me2Sn(S4MoVa), see Figure 4c. In the crystal of Me2Sn(SBoVa), both phenyl-C-H…π 
(methoxybenzene) and less common π(chelate)…π(methoxybenzene) interactions are formed. The 
latter interactions have been the subject of a recent comprehensive review [61]. In the present case, 
Sn1-containing molecules interact in this mode via association between the five-membered 
(Sn/S1/N1/N2/C1) chelate ring and a methoxybenzene ring. However, these interactions are best 
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described as edge-to-edge interactions with the closest contact occurring between a nitrogen atom of 
the chelate ring and the benzene-carbon, see Figure 5c. Similar edge-to-edge contacts are found for 
the second independent molecule with the resulting dimeric aggregates being connected into a 
supramolecular layer in the ab-plane by phenyl-C-H…π (methoxybenzene) interactions. Globally, the 
packing comprises alternating layers of molecules of a (with no obvious points of contact between 
the dimeric units) and molecules of b along the c-axis with no directional interactions between 
successive layers. 
B3LYP-derived bond lengths and angles of Me2Sn(S2MoVa), Me2Sn(S4MoVa) and 
Me2Sn(SBoVa) are in excellent agreement with the values obtained from the crystallographic analysis 
above (see Table 1), consistent with the absence of strong directional intermolecular interactions in 
their crystals. For instance, the deviations in the selected bond lengths/angles of Me2Sn(S2MoVa), 
Me2Sn(S4MoVa) and Me2Sn(SBoVa) ranged from 0.002–0.144 Å/0–5.6°, whereby the maximum bond 
length deviation corresponded to the Sn‒N2 bond for Me2Sn(S4MoVa) and the maximum bond angle 
deviation corresponded to the S1‒Sn‒O1 angle for Me2Sn(SBoVa). 
2.6. UV-Vis Absorption Spectroscopy 
The experimental UV-vis spectra of the Schiff bases measured in DMSO exhibited prominent 
absorption bands at 340–348 and 371–389 nm. The corresponding peaks were predicted at 334 and 
377–378 nm using B3LYP. The highest occupied molecular orbital and lowest unoccupied molecular 
orbital (HOMO-LUMO) electron density distribution of the Schiff bases and organotin(IV) 
compounds (see Figure S1) showed that the HOMO was predominantly centred on the thiolate group 
and azomethine moieties of the dithiocarbazate backbone in each of the compounds investigated 
here. Conversely, the LUMO was consistently centred on the 2-hydroxy-3-methoxyphenyl ring, as 
well as on the backbone of the dithiocarbazate moieties. Thus, the 334 nm absorption peak was 
attributed to the n→π* transitions associated with the non-bonding electron pair of the azomethine 
nitrogen and sulphur atoms. There was some π→π* character to this transition as well, relating to 
electron delocalization in the aromatic rings. In the spectra of the organotin(IV) compounds, the 
additional, strong S→SnIV intra-ligand band indicated coordination at 444-447 nm. The presence of 
the S→SnIV LMCT band was corroborated by IR evidence which showed that the tin centre was 
coordinated to the sulphur atom in the organotin(IV) compounds [62]. The HOMO and LUMO of the 
organotin(IV) compounds were comparable to those of the corresponding Schiff bases, i.e., the 
HOMO was largely centred on the backbone of the Schiff bases and the LUMO mostly covered the 2-
hydroxy-3-methoxyphenyl ring as well as the backbone of the Schiff base thus explaining the 
observed n→π* and π→π* transitions at 307–315 and 353–373 nm, respectively. The HOMO and 
LUMO transitions were the same for all the Schiff bases due to their similar structures, the difference 
being only the presence and position of the methyl group attached to the phenyl ring. Complete 
experimental and calculated UV-vis data are listed in Table S7.  
2.7. Biological Assays 
2.7.1. Cytotoxicity 
The Schiff bases and their organotin(IV) compounds were screened for in vitro cytotoxicity 
against a panel of 12 cancer cell lines: EJ-28 (muscle invasive bladder), RT-112 (minimum-invasive 
bladder), HT29 (colon), U87 and SJ-G2 (glioblastoma), MCF-7 (breast), A2780 (ovarian), H460 (lung), 
A431 (skin), DU145 (prostate), BE2-C (neuroblastoma), MIA (pancreatic) and one normal breast cell 
line (MCF-10A) using the MTT metabolic assay (Figure 6). After 72 h of incubation, a dose-dependent 
proliferative effect towards the cancer cell lines was measured at very low micromolar (µM) 
concentrations of the compounds. The growth inhibition concentration of the Schiff bases and their 
organotin(IV) compounds required to inhibit 50% cell proliferation relative to the cells that were 
treated with DMSO (control) are given in Table 2. The stability of these compounds was assessed in 
DMSO as well as in a mixture of DMSO-H2O. The absorbance obtained from UV-vis spectroscopy 
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analysis was monitored for 72 h, and an unchanged pattern in the spectra was indicative that the 
compounds were stable in both the solvent systems tested.  
As outlined earlier, the effect of the substitution in the methyl group on the dithiocarbazate 
backbone on the coordination with the tin ion was explored. The GI50 values for the three Schiff bases 
showed a slight difference; the presence of methyl group at ortho (S2MoVaH) and para (S4MoVaH) 
positions resulted in a slight reduction in potency as compared to SBoVaH. This cytotoxicity 
difference was probably due to the hydrophobic nature of the methyl group [63]. To note, S4MoVaH 
exhibited the lowest potency against HT29 and MIA with GI50 values of 8.0 ± 3.5 and 11 ± 2.3 µM, 
respectively. It was also observed that the coordination of the Schiff bases with diphenyltin(IV) 
induced potent selective growth inhibition in A2780, BE2-C and MIA cells, in which the compounds 
exhibited potency higher than their respective Schiff bases. Cytotoxic selectivity was also observed 
for Ph2Sn(SBoVa) and Ph2Sn(S4MoVa) against MCF-7 with GI50 values of 0.90 ± 0.16 and 0.82 ± 0.14 
µM, respectively. This constituted a potency that was almost thrice higher than that of the 
corresponding Schiff bases, SBoVaH and S4MoVaH which had values of 2.5 ± 0.12 and 3.5 ± 0.00 µM, 
respectively. In addition, Ph2Sn(S4MoVa) exhibited a much higher potency (GI50 value of 0.87 ± 0.22 
µM) than S4MoVaH (GI50 value of 8.0 ± 3.5 µM) against HT-29 cancer cells. A 3-fold greater activity 
against SJ-G2 was observed for Ph2Sn(SBoVa) and Ph2Sn(S2MoVa) with GI50 values of 0.74 ± 0.15 and 
0.84 ± 0.09 µM respectively, than their respective Schiff bases. It is noteworthy to mention that the 
diphenyltin(IV) compounds showed high selectivity against EJ-28, RT-112, MCF-7, A2780, BE2-C, SJ-
G2 and MIA cell lines in the range 1.4-5.0-fold as compared to the normal breast cell line (MCF10A).  
By contrast, dimethyltin(IV) compounds showed almost similar cytotoxicity values when 
assayed against the panel of cancer cell lines suggesting that the presence of two phenyl groups 
coordinated directly to the tin ion improved the potency of the Schiff bases. Electron delocalisation 
over the chelate rings, which increased the lipophilicity of the molecules and favoured their 
permeation through the lipid layer of the cancer cell membranes could also be a contributing factor 
to the enhancement of cytotoxicity [64]. A third contributing factor could be the ease of ability of the 
phenyl planes to intercalate into the base pairs of DNA in the cancer cell lines [8]. To better 
understand the mode of biological action of the compounds that showed promising activity, 
apoptosis assays using the minimally invasive bladder cancer RT-112 cells and DNA binding studies 
were carried out by evaluating the compounds’ mechanism of action. 
2.7.2. Annexin V Assays of Ph2Sn(S2MoVa)Ph2, Ph2Sn(S4MoVa), and Ph2Sn(SBoVa)-Treated RT-112 
Cells 
Cell death usually occurs by apoptosis or necrosis, the latter induces severe inflammation. The 
apoptotic cells containing apoptotic bodies (small membrane-bound vesicles), are engulfed by 
macrophages, and hence no inflammatory response is triggered. On this account, as apoptotic cell 
induction is considered crucial in cytotoxic drug development, investigations using the Annexin V 
assay were performed to study the apoptosis effect on cancer cells of the organotin(IV) compounds. 
The three most highly cytotoxic diphenyltin(IV) compounds at their specific IC50 concentrations were 
chosen for this assay. The analysis was carried out using RT-112, minimum-invasive bladder cancer 
cells with high levels of epidermal growth factor receptor expression. In the early stages of apoptosis, 
changes occurred at the cell surface [65]. The plasma membrane alteration occurs due to the 
translocation of phosphatidyl-serine (PS) from the inner part of the plasma membrane where it is 
normally located on the cytoplasmic surface, to the outer layer. The PS exposed on the cell surface 
has high binding affinity to the Annexin V. In the later stages of apoptosis, as well as necrosis, the 
cell membranes lose their membrane integrity and allows propidium iodide (PI) to enter into the 
nucleus of the cells. Annexin V/PI double staining was used to differentiate viable cells (Annexin V- 
and PI-) in early apoptosis (Annexin V+ and PI−) or late apoptosis (Annexin V+ and PI+) and necrosis 
(annexin V− and PI+) stages [66]. Under fluorescence microscopy, the cells stained by annexin V 
appear green, whereas the cells stained by PI appear red. After 24 h exposure to the diphenyltin(IV) 
compounds, Figure 6 show that the cells undergoing late apoptosis and necrosis features. Thus, this 
assay proved that the diphenyltin(IV) compounds trigger the activation of apoptosis [67]. 
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Table 2. Summary of the in vitro cytotoxicity of the Schiff bases and their organotin(IV) compounds in several cell lines, determined by MTT assay and expressed 
as GI50 values with standard errors. (GI50 is the concentration at which cell growth is inhibited by 50% over 72 h). 
Compounds 
Growth Inhibition Concentration, GI50 (µM) 
EJ-28 RT-112 HT29 U87 MCF-7 A2780 H460 A431 Du145 BE2-C SJ-G2 MIA MCF10A 
S2MoVaH 3.4 ± 0.47 4.6 ± 0.45 3.9 ± 0.71 4.3 ± 0.30 2.7 ± 0.21 3.2 ± 0.15 4.3 ± 0.12 3.8 ± 0.03 4.1 ± 0.09 3.1 ± 0.00 3.0 ± 0.09 4.9 ± 0.37 3.1 ± 0.07 
Ph2Sn(S2MoVa) 0.35 ± 0.05 0.31 ± 0.05 1.8 ± 0.13 4.4 ± 1.7 1.4 ± 0.12 0.23 ± 0.01 2.8 ± 0.00 2.1 ± 0.09 1.7 ± 0.07 0.47 ± 0.05 0.84 ± 0.09 0.34 ± 0.02 1.2 ± 0.30 
Me2Sn(S2MoVa) 2.5 ± 0.78 2.4 ± 0.77 2.7 ± 0.10 3.6 ± 0.23 3.1 ± 0.12 3.1 ± 0.06 3.3 ± 0.13 3.0 ± 0.03 3.9 ± 0.03 2.9 ± 0.03 2.5 ± 0.30 3.9 ± 0.07 3.0 ± 0.09 
S4MoVaH 3.6 ± 0.44 3.2 ± 0.51 8.0 ± 3.5 3.9 ± 0.00 3.5 ± 0.00 3.1 ± 0.40 5.5 ± 0.73 4.2 ± 0.74 5.4 ± 0.23 3.6 ± 0.27 3.3 ± 0.87 11 ± 2.3 3.5 ± 0.23 
Ph2Sn(S4MoVa) 3.1 ± 0.37 1.7 ± 0.49 0.87 ± 0.22 1.3 ± 0.40 0.82 ± 0.14 0.35 ± 0.07 1.9 ± 0.23 1.4 ± 0.38 1.5 ± 0.31 0.53 ± 0.01 1.0 ± 0.16 0.39 ± 0.03 1.1 ± 0.37 
Me2Sn(S4MoVa) >5.0 >5.0 6.9 ± 3.5 3.3 ± 0.18 3.3 ± 0.32 3.1 ± 0.63 4.7 ± 0.46 4.2 ± 0.34 4.2 ± 0.10 3.3 ± 0.23 3.1 ± 0.55 8.9 ± 1.30 3.3 ± 0.15 
SBoVaH 3.1 ± 0.20 3.7 ± 0.57 2.2 ± 0.033 3.1 ± 0.26 2.5 ± 0.12 3.0 ± 0.06 3.3 ± 0.21 3.0 ± 0.15 3.4 ± 0.30 2.8 ± 0.20 2.4 ± 0.26 4.5 ± 0.25 3.0 ± 0.07 
Ph2Sn(SBoVa) 0.32 ± 0.05 0.58 ± 0.29 1.2 ± 0.22 1.1 ± 0.39 0.90 ± 0.16 0.23 ± 0.03 2.2 ± 0.00 1.6 ± 0.07 1.4 ± 0.33 0.50 ± 0.05 0.74 ± 0.15 0.43 ± 0.04 1.3 ± 0.20 
Me2Sn(SBoVa) 3.4 ± 0.30 2.4 ± 0.33 2.8 ± 0.15 4.5 ± 0.19 2.5 ± 0.21 3.2 ± 0.03 3.8 ± 0.10 3.2 ± 0.03 3.2 ± 0.13 2.7 ± 0.13 2.1 ± 0.12 5.0 ± 0.09 2.8 ± 0.41 
Cisplatin 3.97 ± 0.48 3.56 ± 0.88 11.0 ± 2.0 4.0 ± 1.0 6.5 ± 0.8 1.0 ± 0.1 0.9 ± 0.2 2.4 ± 0.3 1.2 ± 0.1 1.9 ± 0.2 0.4 ± 0.1 8.0 ± 1.0 nd 
GI50 (µM): (the colors indicate) =0.1–0.99; =1.0–9.9; =10-100; =nd (not determined). 
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2.7.3. Measurement of Reactive Oxygen Species (ROS) in RT-112 Cells Treated with Ph2Sn(S2MoVa) 
and Ph2Sn(S4MoVa) 
Two compounds with the most promising bioactivity, Ph2Sn(S2MoVa) and Ph2Sn(S4MoVa), 
were selected for further cell apoptosis studies, in order to evaluate the primary damage to biological 
macromolecules through redox reactions, particularly via formation of ROS [68]. ROS are highly 
reactive molecules/radicals (O2, O2•, H2O2, HO•) that are continuously generated during aerobic 
metabolism, but when in excessive amounts, can lead to protein and DNA oxidation, protein cross-
linking and cell death. Estimation of the levels of ROS in cell culture is an important step towards 
better understanding the mechanisms that lead to cell death or disease processes. Figure 7 shows that 
both the Ph2Sn(S2MoVa) and Ph2Sn(S4MoVa) stimulated ROS generation. ROS production was 
measured using the ROS-detecting fluorescent dye DCFH-DA and DMSO was used as a control. Both 
compounds were able to induce ROS production in RT-112 cell lines after 24 h. The significant 
increase in ROS generation supports the findings that the compounds have high potential cytotoxicity 
and suggested that the mechanism of cell death was via the simulation of mitochondrial-initiated 
events [69]. 
 
 
Figure 6. Apoptosis detection through fluorescence microscopy. Cells were treated for 24 h with 
Ph2Sn(SBoVa) (0.58 µM), Ph2Sn(S2MoVa) (0.31 µM) and Ph2Sn(S4MoVa) (1.66 µM) and the negative 
control (DMSO) in complete media. After staining with Annexin V and PI, necrotic and apoptotic cells 
were detected by fluorescence microscopy (20×). 
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Figure 7. Percent reactive oxygen species (ROS) production in RT-112 cells treated with (a) 
Ph2Sn(S2MoVa) (0.31 µM) (b) Ph2Sn(S4MoVa) (1.66 µM) for 24 h and stained with 1 mM DCFH-DA 
for 60 minutes at 37 °C. DMSO and H2O2 acted as negative and positive controls, respectively. 
2.7.4. DNA Interaction Studies 
Both theoretical and experimental DNA binding of the synthesised organotin(IV) compounds 
with DNA were investigated. The interaction of organotin(IV) compounds with CT-DNA was 
elucidated via UV-visible absorption spectroscopy. The electronic spectra of the organotin(IV) 
compounds exhibited three absorption bands around 306–315 nm, 350–377 nm and 433–450 nm, 
which corresponded to intra-ligand transitions and ligand metal charge transfer (LMCT) transitions 
(see below). The absorption spectra of diphenyltin(IV) compounds at a constant concentration (50 
µM) in the absence and the presence of different concentrations of CT-DNA are shown in Figure 8. 
The DNA binding spectra for dimethyltin(IV) compounds are presented in Figure S2. Upon 
increasing concentrations of CT-DNA, hypochromism and bathochromism occurred at around 350-
377 nm indicating strong π–π stacking interactions between the aromatic chromophore of the 
organotin(IV) compounds and the nitrogeneous pair of the DNA strand [11,70]. The same 
hypochromism and bathochromism shifts were also observed in other transitions. In order to 
compare the binding strength of the organotin(IV) compounds to CT-DNA, the intrinsic binding 
constants (Kb) were quantitatively determined and are presented in Table 3. The Kb data showed that 
the compounds had strong binding affinities, potentially enabling them to block enzyme bound to 
the nitrogenous bases of DNA. 
The Gibbs free energies of interaction between the organotin(IV) compounds and DNA ranged 
from −31.0 to −37.6 kJ mol−1, meaning that the interaction of the organotin(IV) compounds with DNA 
was spontaneous [71]. To investigate and understand the interactions between DNA and these 
compounds, molecular docking simulations were carried out. 
Table 3. Binding constants (Kb), hypochromism (%), bathochromic shifts (nm) and Gibbs free energy 
(kJ mol−1) values for the interaction of organotin(IV) compounds with calf thymus DNA (CT-DNA). 
Compounds Binding 
Constant (Kb) 
Hypochromism, 
(%) 
Bathochromism Shift 
(nm) 
Gibbs Free Energy 
(kJ mol−1) 
Ph2Sn(S2MoVa) 6.21 × 105 41.06 6 −33.1 
Me2Sn(S2MoVa) 3.46 × 105 37.97 10 −31.6 
Ph2Sn(S4MoVa) 2.67 × 105 28.25 4 −31.0 
Me2Sn(S4MoVa) 4.15 × 105 43.72 7 −32.1 
Ph2Sn(SBoVa) 1.21 × 106 70.72 12 −34.7 
Me2Sn(SBoVa) 3.91 × 106 53.26 1 −37.6 
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Figure 8. (a) Electronic absorption spectra of (i) Ph2Sn(S2MoVa), (ii) Ph2Sn(S4MoVa) and (iii) 
Ph2Sn(SBoVa); (b) Plot of [DNA]/εa − εf vs. [DNA] for absorption titration of DNA with (i) 
Ph2Sn(S2MoVa), (ii) Ph2Sn(S4MoVa) and (iii) Ph2Sn(SBoVa). The arrow indicates the change in 
absorbance in tandem with increasing DNA concentration. 
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2.8. Molecular Docking Studies 
Molecular docking analyses of the organotin(IV) compounds with the DNA duplex of sequence 
d(CGCGAATTCGCG)2 dodecamer (PDB ID: 1BNA) were performed and results are detailed in Table 
4. These simulations demonstrated that the organotin(IV) compounds considered here were 
commensurate with the dimensions of the grooves of the DNA duplex sequence. Figure 9(a) revealed 
that these small organotin(IV) compounds fitted well into the A-T rich region of the minor grooves 
of DNA. Generally, the electronegativity of A-T sequences provided better van der Waals interactions 
due to their narrower sequences compared to G-C regions. In groove regions, van der Waals and 
hydrophobic interactions play important roles in the stabilisation of compounds [72]. Their 
interactions therefore, involved hydrogen bonding, hydrophobic and electrostatic interactions with 
lowest binding energies between −9.10 to −10.07 kcal mol−1, which is better than cisplatin (−8.65 kcal 
mol−1) [25]. The interactions occurred either through the phosphate-oxygen atom of the DNA or via 
DNA bases. Ph2Sn(S2MoVa) exhibited two hydrogen bonding interactions through methoxy-oxygen 
atoms and methyl groups with phosphate-oxygen atoms of DT20 and DT8, respectively. Similar 
interactions were observed for Me2Sn(S2MoVa) through the oxygen atom of methoxy group with the 
phosphate backbone atoms of DT19; Ph2Sn(S4MoVa), Me2Sn(S4MoVa) and Me2Sn(SBoVa) interacted 
through the carbon atoms of the azomethine group with oxygen atoms of thymine base, DT8, DT7 
and DT20, respectively. Detailed interactions between the organotin(IV) compounds and DNA 
residues are presented in Figure 9b. Thus, on the basis of docking studies, it could be inferred that 
the cytotoxic activities of organotin(IV) compounds could have arisen due to effective interactions of 
the compounds with DNA. 
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Table 4. Molecular docking data for the organotin(IV) compounds with B-DNA (PDB ID: 1BNA) dodecamer d(CGCGAATTCGCG)2. 
Complex 
Final Intermolecular Energy, kcal mol−1 Final total 
Internal Energy 
(2), kcal mol−1 
Torsional Free 
Energy (3),  
kcal mol−1 
Unbound System’s 
Energy [=(2)] (4), 
kcal mol−1 
Estimated Free Energy of 
Binding [(1) + (2) + (3) − 
(4)], kcal mol−1 
Estimated Free Energy of 
Binding, kJ mol−1 vdW + Hbond + 
desolv. Energy 
Electrostatic 
Energy 
Total 
(1) 
Ph2Sn(S2MoVa) −11.46 0.00 −11.47 −2.19 1.79 −2.19 −9.68 −40.50 
Me2Sn(S2MoVa) −10.27 −0.03 −10.30 0.57 1.19 −0.57 −9.10 −38.07 
Ph2Sn(S4MoVa) −11.87 0.01 −11.86 −1.82 1.79 −1.82 −10.07 −42.13 
Me2Sn(S4MoVa) −10.84 0.00 −10.83 −0.53 1.19 −0.53 −9.64 −40.33 
Ph2Sn(SBoVa) −11.07 0.03 −11.04 −1.86 1.79 −1.86 −9.25 −38.70 
Me2Sn(SBoVa) −10.58 −0.01 −10.59 −0.54 1.19 −0.54 −9.40 −39.33 
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Figure 9. (a) Schematic representation of organotin(IV) compounds that fit well in the grooves of the 
DNA strand obtained by docking simulations. The two double-stranded DNA comprise of the 
phosphate deoxyribose backbone with guanine (DG, red), cytosine (DC, blue), adenine (DA, pink) 
and thymine (DT, orange). (b) Molecular interactions of organotin(IV) compounds within the grooves 
of double stranded DNA residues. 
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3. Experimental 
3.1. Physical Measurements 
Melting points were determined using an Electrothermal digital melting point apparatus (Cole-
Parmer, Staffordshire, UK). IR spectra were recorded using the Perkin Elmer Spectrum 100 with 
Universal ATR Polarization (PerkinElmer, Boston, MA, USA) in the range 4000–280 cm−1. C, H, and 
N elemental analyses were carried out using a LECO CHNS-932 instrument (LECO, Saint Joseph, MI, 
USA). Molar conductivities of 10−3 M solutions of the organotin(IV) compounds in DMSO were 
measured at 27 °C using a Jenway 4310 conductivity meter fitted with a dip-type cell with a platinised 
electrode (Cole-Parmer, Staffordshire, UK). Electronic spectra were recorded on a Shimadzu UV-1650 
PC recording spectrophotometer (1000–200 nm) (Shimadzu, Tokyo, Japan). 1H and 13C NMR spectra 
were recorded using an NMR JNM ECA400 spectrometer (JEOL, Peabody, MA, USA) with 
tetramethylsilane (TMS) was used as an internal standard. 119Sn NMR were recorded using a JOEL 
NMR spectrophotometer (JEOL, Peabody, MA, USA). The mass spectra were recorded using a 
Shimadzu GC-MS QP2010Plus mass spectrometer (Shimadzu, Tokyo, Japan). 
3.2. Materials 
All solvents and reagents were of analytical reagent grade and used without further purification. 
Chemicals: Hydrazine hydrate, 80% (Fluka, Buchs, Switzerland), benzylchloride, ≥99% (Merck, New 
York, NY, USA), 2-methybenzyl chloride, 99% (ACROS, Carson, CA, USA), 4-methylbenzyl chloride 
(ACROS, Carson, CA, USA), potassium hydroxide (HmbG, Hamburg, Germany), carbon disulfide 
(BDH, Radnor, PA, USA), 2-hydroxy-3-methoxybenzaldehyde (Merck, New York, NY, USA) and 
nitric acid, 65% (Thermo Fisher Scientific Inc., Waltham, MA, USA), dichlorodiphenyltin(IV) and 
dichlorodimethyltin(IV) (Sigma Aldrich, St. Louis, MO, USA). Solvents: Acetonitrile (Baker, Sanford, 
ME, USA), absolute ethanol, 99.8% (Scharlau, Barcelona, Spain), ethanol, 95% (John Kollin 
Corporation, Midlothian, UK), methanol (Fisher, Pittsburgh, PA, USA) and dimethylsulfoxide 
(Scharlau, Barcelona, Spain). 
Chemicals used for biological assay were purchased as follows: RPMI-1640 medium with L-
glutamine (without sodium bicarbonate) (Sigma Aldrich, St. Louis, MO, USA), 
Penicillin/Streptomycin solution (Biowest, Riverside, MO, USA), Fetal Bovine Serum (sterile filtered) 
(Biowest, Riverside, MO, USA), Trypsin 0.25%, EDTA in HSSS without calcium, magnesium, with 
phenol red (Biowest, Riverside, MO, USA), Phosphate Buffered Saline (PBS) 10× concentrate (Sigma 
Aldrich, St. Louis, MO, USA), dimethyl sulfoxide (DMSO) (Fisher Scientific, Pittsburgh, PA, USA), 
Annexin-V-FLUOS Staining Kit containing propidium iodide (PI), Annexin-V-Fluorescein, and 
incubation buffer (ROCHE, Basel, Switzerland). OxiSelect™ Intracellular ROS Assay Kit (Green 
Fluorescence) containing 20× DCFH-DA, 2,7-dichlorofluorescein (DCF) Standard, Hydrogen 
Peroxide, and 2× Cell Lysis Buffer (Cell Biolabs, San Diego, CA, USA). 
3.3. Synthesis 
3.3.1. S-N-R-Benzyldithiocarbazates (N = 2,3, R = Methyl) 
The procedure was adapted from that reported by Tarafder and co-workers [73–75]. Potassium 
hydroxide (11.4 g, 0.2 mol) was dissolved in ethanol (70 mL, 90%). Then, hydrazine hydrate (10 g, 0.2 
mol) was added and the mixture was maintained at 0 °C in an ice-salt bath. Carbon disulfide (15.2 g, 
0.2 mol) was added dropwise with vigorous stirring (750 rpm) over a period of 1 h. The two layers 
that formed were separated and the light-brown lower layer was dissolved in 40% ethanol (60 mL) 
below 5 °C. The mixture was kept in an ice-bath and 2-methylbenzyl chloride/4-methylbenzyl 
chloride/benzyl chloride (0.2 mol) was added dropwise with vigorous stirring. The sticky white 
product, which formed, S2MBDTC, S4MBDTC or SBDTC, was filtered and left to dry overnight in a 
desiccator over anhydrous silica gel. The products were then kept in a freezer. 
3.3.2. S-2-Methybenzyl-β-N-(2-hydroxy-3-methoxybenzylmethylene) Dithiocarbazate (S2MoVaH) 
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The synthesis of the Schiff base, S2MoVaH was adapted from the literature [76,77]. S-2-
methylbenzyldithiocarbazate (S2MBDTC) (2.12 g, 10 mmol) was dissolved in hot acetonitrile (100 
cm3) and added to an equimolar amount of 2-hydroxy-3-methoxybenzaldehyde (1.52 g, 10 mmol) in 
absolute ethanol (20 cm3). The mixture was heated (80 °C) with continuous stirring for about 30 min 
and then allowed to stand overnight at room temperature. The resultant product was recrystallised 
from CH3CN/EtOH (1:1) to give a light yellow crystalline solid that was filtered and washed with 
cold absolute ethanol. Yield: 65%. M.p.: 180–183 °C. Elemental analysis: calculated for C17H18N2O2S2: 
C, 58.93; H, 5.24; N, 8.09. Found: C, 59.75; H, 5.25; N, 7.81. FT-IR (ATR, cm−1): 3084, (N–H); 1600, 
(C=N); 1117, (N–N); 1026, (C=S). 1H NMR (DMSO-d6) δ (ppm.): 13.34 (s,1H, NH), 9.57 (s, 1H, OH), 
8.51 (s, 1H, CH), 6.75–7.34 (multiplet, 7H, Ar–H), 4.40 (s, 2H, CH2), 3.76 (s, 3H, O–CH3), 2.30 (s,3H, 
Bz–CH3); 13C NMR (DMSO-d6) δ (ppm.): 196.1 (C=S), 148.6 (C=N); 148.6, 147.4, 144.9, 137.4, 134.4, 
130.8, 130.7, 128.2, 126.7, 120.0, 118.8, 114.4 (aromatic-C), 56.4 (O–CH3), 36.9 (CH2), 19.4 (CH3). m/z 
calculated for C17H18N2O2S2: 346.47, found: 346.15. 
3.3.3. S-4-Methybenzyl-β-N-(2-hydroxy-3-methoxybenzylmethylene)dithiocarbazate (S4MoVaH) 
The synthesis of the Schiff base, S4MoVaH was similar to S2MoVaH [76,77]. S-4-
methylbenzyldithiocarbazate (S4MBDTC) (2.12 g, 10 mmol) was dissolved in hot acetonitrile (100 
cm3) and added to an equimolar amount of 2-hydroxy-3-methoxybenzaldehyde (1.52 g, 10 mmol) in 
absolute ethanol (20 cm3). The mixture was heated (80 °C) with continuous stirring for about 30 min 
and then allowed to stand overnight at room temperature. The resultant product was recrystallised 
from CH3CN/EtOH (1:1) to give a light yellow crystalline solid that was filtered and washed with 
cold absolute ethanol. Yield: 68%. M.p.: 177–178 °C. Elemental analysis: Calculated for C17H18N2O2S2: 
C, 58.93; H, 5.24; N, 8.09. Found: C, 58.48; H, 5.18; N, 8.76. FT-IR (ATR, cm−1): 3092, (N–H); 1598, 
(C=N); 1118, (N–N); 1030, (C=S). 1H NMR (DMSO-d6) δ (ppm.): 13.32 (s,1H, NH), 9.61 (s, 1H, OH), 
8.51 (s, 1H, CH), 6.97–7.24 (multiplet, 7H, Ar–H), 4.39 (s, 2H, CH2), 3.76 (s, 3H, O-CH3), 2.23 (s,3H, 
Bz–CH3); 13C NMR (DMSO-d6) δ (ppm.): 196.2 (C=S), 148.6 (C=N); 148.6, 147.4, 145.0, 137.0, 134.0, 
129.7, 129.6, 120.0, 118.8, 114.4 (aromatic-C), 56.4 (O–CH3), 38.0 (CH2), 21.2 (CH3). m/z calculated for 
C17H18N2O2S2: 346.47, found: 346.10. 
3.3.4. S-Benzyl-β-N-(2-hydroxy-3-methoxybenzylmethylene) Dithiocarbazate (SBoVaH) 
The synthesis of Schiff base, SBoVaH was adapted from literature [76,77] S-
benzyldithiocarbazate (SBDTC) (1.98 g, 10 mmol) was dissolved in hot absolute ethanol (100 cm3) and 
added to an equimolar amount of 2-hydroxy-3-methoxybenzaldehyde (1.52 g, 10 mmol) in absolute 
ethanol (20 cm3). The mixture was heated (78 °C) with continuous stirring for about 30 min and then 
allowed to stand overnight at room temperature. The resultant product was recrystallised from 
ethanol to yield light yellow crystals that were filtered and washed with cold absolute ethanol. Yield: 
70%. M.p.: 173–174 °C. Elemental analysis: calculated for C16H16N2O2S2: C, 57.81; H, 4.85; N, 8.43. 
Found: C, 58.21; H, 4.87; N, 8.28. FT-IR (ATR, cm−1): 3089, (N–H); 1598, (C=N); 1125, (N–N); 1030, 
(C=S). 1H NMR (DMSO-d6) δ (ppm.): 13.34 (s,1H, NH), 9.58 (s, 1H, OH), 8.52 (s, 1H, CH), 6.77-7.37 
(multiplet, 8H, Ar–H), 4.45 (s, 2H, CH2), 3.77 (s, 3H, O–CH3); 13C NMR (DMSO-d6) δ (ppm.): 196.1 
(C=S), 148.6 (C=N); 148.6, 147.4, 144.9, 137.3, 129.8, 129.0, 127.8, 120.0, 118.8, 114.4 (aromatic-C), 56.4 
(CH3), 38.1 (CH2). m/z calculated for C16H16N2O2S2: 332.44, found: 332.10. 
3.3.5. Diphenyltin(IV) Compounds 
Each Schiff base (1 mmol) was dissolved in absolute ethanol (50 cm3) and mixed with an 
ethanolic solution (10 cm3) of Ph2SnCl2 (0.34 g, 1 mmol). The resultant yellow solution was refluxed 
for ca. 6 h. The mixture was left overnight at room temperature and the reduction in the volume of 
the reaction mixture resulted in the deposition of a yellow precipitate which was filtered off and 
recrystallised from methanol. 
Diphenyltin(IV) [S-2-Methybenzyl-β-N-(2-hydroxy-3-methoxybenzylmethylene) dithiocarbazate], 
Ph2Sn(S2MoVa) 
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Yellow solid. Yield: 44%. Melting point: 149–150 °C. Elemental analysis: Calculated for 
C29H34N2O6S2Sn: C, 56.42; H, 4.24; N, 4.54. Found: C, 56.52; H, 4.97; N, 4.06. FT-IR (ATR, cm−1): 1588, 
(C=N); 1076, (N–N); 963, (C=S). 1H NMR (CDCl3) δ (ppm.): 8.77 (s, 1H, CH), 4.47 (s, 2H, CH2), 2.43 (s, 
3H, CH3), 3.97 (s, 3H, O–CH3), 6.69-7.94 (multiplet, 17H, Ar–H); 13C NMR (CDCl3) δ (ppm.): 171.9 (C–
S), 166.1 (C=N); 159.3, 152.0, 142.0, 136.1, 130.6, 130.4, 130.2, 128.9, 127.9, 126.3, 126.1, 117.2, 116.2 
(aromatic-C), 56.6 (O-CH3), 34.4 (CH2), 19.4 (Bz–CH3).119Sn NMR (CDCl3) δ (ppm.): −236.38. 
Diphenyltin(IV) [S-4-Methybenzyl-β-N-(2-hydroxy-3-methoxybenzylmethylene) dithiocarbazate], 
Ph2Sn(S4MoVa) 
Yellow solid. Yield: 72%. Melting point: 130–132 °C. Elemental analysis calculated for 
C17H17N2O2S2: C, 54.82; H, 4.44; N, 4.41. Found: C, 54.42; H, 4.05; N, 4.18. FT-IR (ATR, cm−1): 1589, 
(C=N); 1068, (N–N); 958, (C=S). 1H NMR (CDCl3) δ (ppm.): 8.74 (s, 1H, CH), 4.41 (s, 2H, CH2), 2.32 (s, 
3H, CH3), 3.94 (s,3H, O–CH3), 6.69-7.93 (multiplet, 17H, Ar–H); 13C NMR (CDCl3) δ (ppm.): 171.8 (C–
S), 166.1 (C=N), 159.3, 152.0, 142.0, 137.2, 136.0, 135.8, 133.5, 130.2, 129.4, 129.2, 128.9, 126.1, 117.2, 116.3 
(aromatic-C), 56.6 (O–CH3), 36.0 (CH2), 21.2 (Bz–CH3).119Sn NMR (CDCl3) δ (ppm.): −236.22. 
Diphenyltin(IV) [S-Benzyl-β-N-(2-hydroxy-3-methoxybenzylmethylene) dithiocarbazate], 
Ph2Sn(SBoVa) 
Yellow crystals. Yield: 51%. Melting point: 131–133 °C. Elemental analysis calculated for 
C28H24N2O2S2Sn: C, 55.74; H, 4.01; N, 4.64. Found: C, 56.35; H, 3.91; N, 4.98. FT-IR (ATR, cm−1): 1579, 
(C=N); 1019, (N–N); 958, (C=S). 1H NMR (CDCl3) δ (ppm.): 8.74 (s, 1H, CH), 4.45 (s, 2H, CH2), 3.96 (s, 
3H, O-CH3), 6.69-7.93 (multiplet, 18H, Ar–H); 13C NMR (CDCl3) δ (ppm.): 171.6 (C–S), 166.2 (C=N), 
152.0, 141.9, 136.7, 136.1, 130.3, 129.3, 128.9, 128.7, 127.5, 126.1, 117.2, 117.1, 116.2, 115.2, (aromatic-C), 
56.6 (O–CH3), 36.1 (CH2). 119Sn NMR (CDCl3) δ (ppm.): −236.07. 
3.3.6. Dimethyltin(IV) Compounds 
Each Schiff base (1 mmol) was dissolved separately in absolute ethanol (50 cm3) and 
dichloromethane (DCM) (20 cm3) and then mixed with an ethanolic solution (10 cm3) of Me2SnCl2 
(0.22 g, 1 mmol). The resultant yellow solution was refluxed for ca. 6 h. The mixture was left overnight 
at room temperature and kept for few days yielding brown crystals that were suitable for single 
crystal X-ray diffraction analysis. 
Dimethyltin(IV) [S-2-Methybenzyl-β-N-(2-hydroxy-3-methoxybenzylmethylene) dithiocarbazate], 
Me2Sn(S2MoVa) 
Yellow crystals. Yield: 78%. Melting point: 128–130 °C. Elemental analysis calculated for 
C19H22N2O2S2Sn: C, 46.27; H, 4.50; N, 5.68. Found: C, 46.52; H, 4.51; N, 5.82. FT-IR (ATR, cm−1): 1580, 
(C=N); 1076, (N–N); 959, (C=S). 1H NMR (CDCl3) δ (ppm.): 8.76 (s, 1H, CH), 4.42 (s, 2H, CH2), 2.42 (s, 
3H, CH3), 3.85 (s,3H, O–CH3), 6.69–7.34 (multiplet, 7H, Ar–H), 0.97 (Sn–CH3); 13C NMR (CDCl3) δ 
(ppm.): 173.9 (C–S), 166.3 (C=N), 158.5, 151.5, 137.2, 134.1, 130.6, 130.4, 127.9, 126.3, 126.1, 116.9, 116.5, 
115.9 (aromatic-C), 56.3 (CH3), 34.6 (CH2), 19.4 (Bz–CH3), 7.1 (Sn–CH3).119Sn NMR (CDCl3) δ (ppm.): 
−109.41. 
Dimethyltin(IV) [S-4-Methybenzyl-β-N-(2-hydroxy-3-methoxybenzylmethylene) dithiocarbazate], 
Me2Sn(S4MoVa) 
Yellow crystals. Yield: 55%. Melting point: 98–102 °C. Elemental analysis calculated for 
C19H22N2O2S2Sn: C, 46.27; H, 4.50; N, 5.68. Found: C, 47.07; H, 4.66; N, 6.11. FT-IR (ATR, cm−1): 1589, 
(C=N); 1071, (N–N); 958, (C=S). 1H NMR (CDCl3) δ (ppm.): 8.73 (s, 1H, CH), 4.36 (s, 2H, CH2), 2.32 (s, 
3H, CH3), 3.84 (s, 3H, O-CH3), 6.69–7.27 (multiplet, 7H, Ar–H), 0.95 (Sn–CH3); 13C NMR (CDCl3) δ 
(ppm.): 173.7 (C–S), 166.2 (C=N), 158.5, 151.5, 137.1, 133.6, 129.2, 126.1, 119.5, 116.8, 116.4, 115.9 
(aromatic-C), 56.3 (CH3), 36.2 (CH2), 21.2 (Bz–CH3), 7.1 (Sn–CH3). 119Sn NMR (CDCl3) δ (ppm.): 
−109.17. 
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Dimethyltin(IV) [S-Benzyl-β-N-(2-hydroxy-3-methoxybenzylmethylene) dithiocarbazate], 
Me2Sn(SBoVa) 
Yellow crystals. Yield: 48%. Melting point: 104–106 °C. Analysis calculated for C18H20N2O2S2Sn: 
C, 45.11; H, 4.21; N, 5.85. Found: C, 45.36; H, 4.16; N, 6.02. FT-IR (ATR, cm−1): 1581, (C=N); 1026, (N–
N); 959, (C=S). 1H NMR (CDCl3) δ (ppm.): 8.73 (s, 1H, CH), 4.40 (s, 2H, CH2), 3.85 (s, 3H, O–CH3), 6.69-
7.40 (multiplet, 8H, Ar–H), 0.95 (Sn–CH3); 13C NMR (CDCl3) δ (ppm.): 173.6 (C–S), 166.3 (C=N), 158.5, 
151.5, 136.8, 129.3, 128.7, 127.4, 126.1, 116.9, 116.5, 115.9 (aromatic-C), 56.3 (O–CH3), 36.4 (CH2), 7.1 
(Sn–CH3); 119Sn NMR (CDCl3) δ (ppm.): −108.94. 
3.4. Single Crystal X-ray Structure Determination 
Crystals suitable for single-crystal X-ray diffraction studies were obtained for Me2Sn(S2MoVa), 
Me2Sn(S4MoVa) and Me2Sn(SBoVa). Unfortunately, suitable crystals for the diphenyltin(IV) 
compounds were not able to be obtained despite repeated crystal-growth attempts using various 
techniques and solvent systems. The intensity data for Me2Sn(S2MoVa), Me2Sn(S4MoVa) and 
Me2Sn(SBoVa) were measured at T = 150 K on an Oxford Diffraction Gemini E CCD diffractometer 
(Oxford Diffraction Ltd., Agilent Technologies, Santa Clara, CA, USA) fitted with Mo Kα radiation 
(λ = 0.71073 Å) so that θmax was 29.4°. Data reduction, including analytical absorption correction, was 
accomplished with CrysAlisPro (Oxford Diffraction Ltd., UK) [78]. The structures were solved by 
direct methods [79] and refined (anisotropic displacement parameters, C-bound H atoms in the riding 
model approximation) on F2. A weighting scheme w = 1/[σ2(Fo2) + (aP)2 + bP] where P = (Fo2 + 2Fc2)/3) 
[80] was introduced in each case. The crystal of Sn(S2MoVa)Me2 was refined as a twin with the 
fraction of the minor component being 0.1664(20); details are given in the deposited CIF. In the final 
cycles of the refinement of Me2Sn(SBoVa), four reflections, i.e., (−3 4 0), (−1 −1 5), (0 6 0) and (−3 4 4), 
were omitted owing to poor agreement. The molecular structure diagrams was generated with 
ORTEP for Windows [81] with 35, 50 and 70% displacement ellipsoids for Me2Sn(S2MoVa), 
Me2Sn(S4MoVa) and Me2Sn(SBoVa), respectively, and the packing diagrams were drawn with 
DIAMOND (Crystal Impact, GbR, Bonn, Germany) [82]. Additional data analysis was carried out 
with PLATON [83]. Crystal data and refinement details are given in Table 5. 
Table 5. Crystal data and refinement details for compounds Me2Sn(S2MoVa), Me2Sn(S4MoVa) and 
Me2Sn(SBoVa). 
Compound Me2Sn(S2MoVa) Me2Sn(S4MoVa) Me2Sn(SBoVa) 
Formula C19H22N2O2S2Sn C19H22N2O2S2Sn C18H20N2O2S2Sn 
Formula weight 493.19 493.19 479.19 
Crystal colour light-yellow light-yellow light-yellow 
Crystal size/mm3 0.03 × 0.05 × 0.10 0.05 × 0.13 × 0.20 0.03 × 0.05 × 0.10 
Crystal system Monoclinic Triclinic Triclinic 
Space group Pn P1¯ P1¯ 
a/Å 11.3716(9) 10.5908(4) 8.9408(4) 
b/Å 12.0262(8) 13.9243(5) 10.4182(4) 
c/Å 16.3644(15) 14.3974(5) 22.6034(12) 
α/° 90 95.596(3) 97.713(4) 
β/° 109.285(9) 93.693(3) 94.600(4) 
γ/° 90 102.116(2) 111.634(4) 
V/Å3 2112.4(3) 2058.11(13) 1920.11(16) 
Z 4 4 4 
Dc/g cm−3 1.551 1.592 1.658 
F(000) 992 992 960 
µ(MoKα)/mm−1 1.422 1.46 1.562 
Measured data 6348 18090 15229 
θ range/° 3.6–29.4 3.5–29.4 3.4–29.4 
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Unique data 6348 9402 8720 
Observed data (I ≥ 2.0σ(I)) 5090 7605 6671 
No. parameters 478 477 457 
R, obs. data; all data 0.037; 0.064 0.034; 0.070 0.041; 0.083 
a; b in weighting scheme 0.022; 0 0.026; 0.240 0.032; 0.781 
Rw, obs. data; all data 0.055; 0.074 0.049; 0.078 0.062; 0.092 
GoF 0.99 1.01 1.01 
Range of residual electron    
density peaks/eÅ−3 −0.56–0.66 −0.46–0.75 −1.03–0.63 
3.5. Computational Methods 
3.5.1. Density Functional Theory (DFT) Calculations 
All DFT calculations were performed using Gaussian09 software (Gaussian Inc., Wallingford, CT, 
USA) [84] and Gaussview5 program (Semichem, Inc., Shawnee Mission, KS, USA) [85] was used to 
visualise the graphics. The molecular structures and geometries of the Schiff bases and organotin(IV) 
compounds were fully optimised from the X-ray crystallographic structures using density functional 
theory (DFT) method with the B3LYP [86,87] hybrid exchange correlation functional with LanL2DZ 
pseudopotential on Sn [88–90] and 6-311G(d,p) Pople basis set for all other atoms. Vibrational 
frequencies were calculated via the harmonic approximation to ensure that all optimised structured 
corresponded to local minima of the potential energy surface. The electronic stabilities of the 
optimised geometries were computed using the time-dependent density functional theory (TD-DFT) 
formalism [91,92] and included solvation effects (DMSO) via the polarisable continuum method 
(PCM) [93–95], using the same basis set. 
3.5.2. Molecular Docking Studies 
The coordinates of B-DNA (PDB ID: 1BNA) dodecamer d(CGCGAATTCGCG)2 was obtained 
from the Protein Data Bank (http://www.rcsb.org/pdb). The coordinates of the dimethyltin(IV) 
compounds, Me2Sn(S2MoVa), Me2Sn(S4MoVa) and Me2Sn(SBoVa) were taken from their crystal 
structures as a Crystallographic Information File (CIF) and converted to the Protein Data Bank (PDB) 
format using Mercury software (The Cambridge Crystallographic Data Centre, Cambridge, UK) [96], 
whereas the coordinates for Ph2Sn(S2MoVa), Ph2Sn(S4MoVa) and Ph2Sn(SBoVa) were obtained after 
minimisation of energy using DFT method. Molecular docking studies were carried out using the 
AutoDock Tools version 1.5.6 and the AutoDock version 4.2.5.1 program (Molecular Graphics 
Laboratory, La Jolla, CA, USA) [97]. Water molecules were removed, polar hydrogen atoms and 
Kollman charges were added to the receptor (DNA sequences). In the docking analysis, the binding 
site was assigned across all of the minor and major grooves of the DNA molecule, which was enclosed 
in a 64 × 64 × 122 grid box with a grid spacing of 0.375 Å. AutoDock was ran using the following 
parameters: 30 docking trials, population size of 300, maximum number of energy evaluation ranges 
of 2,500,000, maximum number of generations of 27,000, mutation rate of 0.02, cross-over rate of 0.8 
and the default values were used for other parameters. The parameter file of Autodock was modified 
to incorporate van der Waals interactions and other required parameters for Sn obtained from the 
Autodock website [98]. The lowest binding energy of the conformation from the highest cluster was 
selected as the best binding conformation between the ligand and receptor. 
3.6. Biological Assays 
3.6.1. MTT Assays 
The inhibitory effect of the synthesised compounds on the growth of bladder (EJ-28 and RT-112) 
cancer cells was evaluated by MTT assay. The compounds were dissolved in DMSO and diluted in 
culture medium, where the final concentration of DMSO did not exceed 0.05% (v/v) and was not toxic 
to the cancer cells. RT-112 and EJ-28, human bladder cancer cell lines used in this study (ATCC, 
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Manassas, VA, USA) were cultured in RPMI-1640 (High glucose) medium supplemented with 10% 
fetal bovine serum containing 1% penicillin. The cells were cultured at 37 °C in a humidified 
atmosphere of 5% CO2 in air. Cells were seeded in 96-well plates at 6000 cells per well for 24 h, then 
they were treated with different concentrations of compounds for 72 h. The medium was 
subsequently removed and the wells were washed with 200 µL of phosphate buffer saline. Aliquots 
of 20 µL of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) was added to each 
well and incubated for 4 h at 37 °C. Aliquots of 200 µL of media was then removed from each well 
and 200 µL of DMSO was added. Optical density (OD) was measured using an ELISA plate reader at 
570 nm. Control wells (100% viability), containing media and DMSO, were included in all the 
experiments. All data points represented an average of triplicate assays. Cytotoxicity was expressed 
as CD50, i.e., the concentration that reduced the absorbance of treated cells by 50% with reference to 
the control (untreated cells) [99]. 
For HT29 (colon), U87 and SJ-G2 (glioblastoma), MCF-7 (breast), A2780 (ovarian), H460 (lung), 
A431 (skin), Du145 (prostate), BE2-C (neuroblastoma), MIA (pancreas) cell lines and one normal 
breast cell line, MCF-10A (normal breast), the MTT assays were performed using the following 
method: 
Cell Culture and Stock Solutions 
Stock solutions were prepared as follows and stored at −20 °C: Trial compounds were stored as 
10 mM solutions in DMSO. All cell lines were cultured in a humidified atmosphere 5% CO2 at 37 °C. 
The cancer cell lines were maintained in Dulbecco’s modified Eagle’s medium (DMEM) (Trace 
Biosciences) supplemented with 10% foetal bovine serum, 10 mM sodium bicarbonate, penicillin (100 
IU/mL), streptomycin (100 µg/mL) and glutamine (4 mM). The normal cell line, MCF-10A was 
cultured in DMEM:F12 (1:1) cell culture media, 5% heat inactivated horse serum, supplemented with 
penicillin (50 IU/mL), streptomycin (50 µg/mL), 20mM Hepes, L-glutamine (2 mM), epidermal 
growth factor (20 ng/mL), hydrocortisone (500 ng/mL), cholera toxin (100 ng/mL) and insulin (10 
µg/mL). 
In Vitro Growth Inhibition Assay 
Cells in logarithmic growth were transferred to 96-well plates. Cytotoxicity was determined by 
plating cells in duplicate in 100 µL medium at a density of 2500–4000 cells/well. On day 0 (24 h after 
plating), when the cells were in logarithmic growth, 100 µL medium, with or without the test agent, 
was added to each well. After 72 h drug exposure, growth inhibitory effects were evaluated using 
the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay and absorbance read 
at 540 nm. Percentage growth inhibition was determined at a fixed drug concentration of 25 µM. A 
value of 100% was indicative of complete cell growth inhibition. Those analogues showing 
appreciable percentage growth inhibition underwent further dose-response analysis allowing for the 
calculation of a GI50 value. This value is the drug concentration at which cell growth is 50% inhibited 
based on the difference between the optical density values on day 0 and those at the end of drug 
exposure [100,101]. 
3.6.2. Quantification of Apoptosis by Annexin V 
The apoptotic death of RT-112 cells was measured by fluorescence microscopy using Annexin 
V/ PI double-staining. To observe the effect of the diphenyltin(IV) compounds on cell apoptosis, RT-
112 cells, which are minimum invasive bladder cancer cells were seeded in 6-well plates at 1 × 106 
cells per well. After growth overnight, the inhibition concentration obtained from the CD50 analysis 
was used to treat the cells. After 24 h, the cells were washed with phosphate buffer saline (PBS) and 
100 µL of Annexin-V-FLUOS labelling solution containing the incubation buffer and then, propidium 
iodide (PI) solution was added. The plate was then incubated for 10–15 min at 15–25 °C and analysed 
by fluorescence microscopy with a Fluorescence Inverted Microscope (Olympus IX51, Waltham, MA, 
USA). Green staining of the plasma membrane indicated that the cells had bound to Annexin-V. The 
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cells that showed red staining were considered to have lost their membrane integrity. The cells 
stained green were concluded to be apoptotic cells; the cells with both green and red staining were 
concluded as late apoptotic cells whereas the cells that showed only red staining were considered as 
necrotic cells [102]. 
3.6.3. Measurement of Reactive Oxygen Species (ROS) 
Intracellular ROS measurements were used to assess antioxidant or ROS activity. Measurements 
were performed using a fluorescence plate reader following to the procedure outlines in the ROS 
detection kit (OxiSelect™). In brief, RT-112 cells were cultured in 100 µL growth medium in a 96-well 
cell culture plate and incubated in an atmosphere of 5% CO2 at 37 °C for a period of 24 h. The growth 
medium was then removed, the cells were loaded with an oxidation sensitive cell-permeable 
fluorescent probe, dichloro-dihydro-fluorescein diacetate (DCFH-DA), and subsequently stabilised 
in the highly reactive DCFH form. In this reactive state, ROS species in living cells were reacted with 
DCFH, which is rapidly oxidized to the highly fluorescent 2′,7′-dichlorodihydrofluorescein (DCF) 
The plates were then incubated for 1 h and the growth medium was removed. The cells in each well 
were washed with PBS and the growth medium containing 3.05 µM of Ph2Sn(S4MoVa) compound, 
negative control (DMSO), or positive control (H2O2) was added. The plates were incubated in an 
atmosphere of 5% CO2 at 37 °C for a period of 24 h. After incubation, the cells were transferred to 
black 96-well plates with the addition of 2× Cell Lysis Buffer. The cells were then read on a standard 
Infinite M200 fluorescence microplate reader (Tecan, Männedorf, Switzerland). The ROS or 
antioxidant content in unknown samples was determined by comparison with the predetermined 
DCF standard curve [103]. 
3.6.4. DNA Binding Studies 
DNA binding experiments were carried out at 25°C. DNA concentration per nucleotide was 
determined using the molar absorption coefficient (6600 M−1 cm−1) at 260 nm [8,104]. Solutions of calf 
thymus (CT) DNA in Tris-HCl buffer containing (5 mM Tris, pH 7.2, 50 mM NaCl) [8] showed 
A260/A280 of 1.9, indicating that the DNA was sufficiently free of proteins and contaminants [105]. 
Absorption titration experiments were performed maintaining the concentration of the organotin(IV) 
compounds solutions at 50 µM and gradually increasing the concentration of CT-DNA. The 
organotin(IV) compounds were dissolved in DMSO and diluted with Tris-HCI buffer at room 
temperature (25 °C). The solutions were scanned over 230–600 nm. Absorbance values were recorded 
10 min after the addition of DNA solution. The binding constant, Kb was determined using the 
equation: 
[DNA]
(εୟ − ε୤) =
[DNA]
(εୠ − ε୤) +
1
Kୠ(εୠ − ε୤)  
where [DNA] is the concentration of DNA in base pairs, εa corresponds to the apparent molar 
extinction coefficient Aabs/[M], εf corresponds to the extinction coefficient for the free organotin [M] 
and εb corresponds to the extinction coefficient for the fully bound organotin compound. 
4. Conclusions 
Organotin(IV) compounds derived from S-substituted dithiocarbazates and o-vanillin were 
synthesised and characterised by elemental analysis and various spectroscopic techniques (UV-
visible, FTIR, 1H, 13C and 119Sn NMR). The molecular structures of Me2Sn(S2MOVa), Me2Sn(S4MOVa) 
and Me2Sn(SBOVa) were elucidated by single crystal X-ray structure analysis which indicated that 
the compounds had five-coordinate C2NOS geometries, derived from thiolate-S1, phenoxide-O1 and 
imine-N atoms of a dinegative, tridentate dithiocarbazate ligand along with two methyl-carbon 
atoms of the methyl groups, which were intermediate between ideal trigonal-bipyramidal and 
square-pyramidal. The in vitro cytotoxicity against a panel of cancer cell lines viz., EJ-28 and RT-112 
(bladder), HT29 (colon), U87 and SJ-G2 (glioblastoma), MCF-7 (breast), A2780 (ovarian), H460 (lung), 
A431 (skin), Du145 (prostate), BE2-C, (neuroblastoma) and MIA (pancreas) cancer cell lines revealed 
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the remarkable cytotoxicity of diphenyltin(IV) compounds for most of the cell lines, which were more 
potent than cisplatin. In order to evaluate the mechanism of death of the organotin(IV) compounds, 
Annexin-V and ROS assays were performed using the RT-112 cell line where the diphenyltin(IV) 
compounds were able to induce apoptosis and ROS generation in the cells. The DNA binding of the 
organotin(IV) compounds were investigated using UV-vis absorption and the diphenyltin(IV) 
compounds bound reasonably well into the groove of DNA with binding constants in the range 105–
106 M−1. The mode of interaction of the organotin(IV) compounds with DNA was further validated 
by molecular docking studies which were in accordance with the experimental results, suggesting 
the strong binding of diphenyltin(IV) at the AT-rich region of the minor groove of DNA. The 
observed trend in the cytotoxicity and binding interactions of organotin(IV) compounds were 
attributed to the nature of the group bound to the Sn(IV) metal centre where the diphenyltin(IV) 
compounds exhibited potent efficacy and were promising leads for cytotoxic drug development. 
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